Presented here are protocols for in vitro biochemical assays using biotin labels that may be widely applicable for studying protein-nucleic acid interactions.
Protein-nucleic acid interactions play important roles in biological processes such as transcription, recombination, and RNA metabolism. Experimental methods to study protein-nucleic acid interactions require the use of fluorescent tags, radioactive isotopes, or other labels to detect and analyze specific target molecules. Biotin, a non-radioactive nucleic acid label, is commonly used in electrophoretic mobility shift assays (EMSA) but has not been regularly employed to monitor protein activity during nucleic acid processes. This protocol illustrates the utility of biotin labeling during in vitro enzymatic reactions, demonstrating that this label works well with a range of different biochemical assays. Specifically, in alignment with previous findings using radioisotope 32P-labeled substrates, it is confirmed via biotin-labeled EMSA that MEIOB (a protein specifically involved in the meiotic recombination) is a DNA-binding protein, that MOV10 (an RNA helicase) resolves biotin-labeled RNA duplex structures, and that MEIOB cleaves biotin-labeled single-stranded DNA. This study demonstrates that biotin is capable of substituting 32P in various nucleic acid-related biochemical assays in vitro.
Protein-nucleic acid interactions are involved in many essential cellular processes such as DNA repair, replication, transcription, RNA processing, and translation. Protein interactions with specific DNA sequences within the chromatin are required for the tight control of gene expression at the transcriptional level1. Precise posttranscriptional regulation of numerous coding and noncoding RNAs necessitates extensive and complicated interactions between any protein and RNA2. These layers of gene expression regulatory mechanism comprise a cascade of dynamic intermolecular events, which are coordinated by interactions of transcription/epigenetic factors or RNA-binding proteins with their nucleic acid targets, as well as protein-protein interactions. To dissect whether proteins in vivo are directly or indirectly associated with nucleic acids and how such associations occur and culminate, in vitro biochemical assays are conducted to examine the binding affinity or enzymatic activity of proteins of interest on designed substrates of DNA and/or RNA.
Many techniques have been developed to detect and characterize nucleic acid-protein complexes, including the electrophoretic mobility shift assay (EMSA), also termed gel retardation assay or band shift assay3,4,5. EMSA is a versatile and sensitive biochemical method that is widely used for studying the direct binding of proteins with nucleic acids. EMSA relies on gel electrophoretic shift in bands, which are routinely visualized using chemiluminescence to detect biotin labels6,7, the fluorescence of fluorophore labels8,9, or by autoradiography of radioactive 32P labels10,11. Other purposes of biochemical studies are the identification and characterization of nucleic acid-processing activity of proteins, such as nuclease-based reactions to assess the cleavage products from nucleic acid substrates12,13,14 and DNA/RNA structure-unwinding assays to evaluate helicase activities15,16,17.
In such enzymatic activity assays, the radioisotope-labeled or fluorophore-labeled nucleic acids are often used as substrates due to their high sensitivity. Analysis of radiographs of enzymatic reactions involving 32P labeled radiotracers has been found to be sensitive and reproducible18. Yet, in an increasing number of laboratories in the world, the usage of radioisotopes is restricted or even prohibited due to the health risks associated with potential exposure. In addition to biosafety concerns, other drawbacks are the required necessary equipment to conduct work with radioisotopes, required radioactivity license, short half-life of 32P (about 14 days), and gradual deterioration of the probe quality due to radiolysis. Thus, alternative non-isotopic methods have been developed (i.e., labeling the probe with fluorophores enables detection by fluorescent imaging19). However, a high-resolution imaging system is needed when using fluorescently labeled probes. Biotin, a commonly used label, readily binds to biological macromolecules such as proteins and nucleic acids. Biotin-streptavidin system operates efficiently and improves detection sensitivity without increasing non-specific background20,21. Besides EMSA, biotin is widely used for protein purification and RNA pull-down, among others22,23,24.
This protocol successfully uses biotin-labeled nucleic acids as substrates for in vitro biochemical assays that include EMSA, in addition to enzymatic reactions in which biotin has not been commonly used. The MEIOB OB domain is constructed and two mutants (truncation and point mutation) are expressed as GST fusion proteins25,26,27, as well as mouse MOV10 recombinant FLAG fusion protein16. This report highlights the effectiveness of this combined protocol for protein purification and biotin-labeled assays for miscellaneous experimental purposes.
1. Protein preparation
2. Nucleic acid preparation
3. In vitro biochemical assays
The protein structure of MEIOB and the expression constructs used in this study are illustrated in Figure 1A. OB folds in MEIOB are compact barrel-like structures that can recognize and interact with single-stranded nucleic acids. One of the OB domains (aa 136-307, construct A) binds single stranded DNA (ssDNA), the truncated protein (aa 136-178 truncations, construct C) and the point mutant form (R235A mutation, construct E) of MEIOB do not have DNA-binding activity26. The GST-MEIOB fusion proteins were overexpressed in BL21 bacteria, with subsequent isolation steps resulting in purified proteins shown by Coomassie blue staining and western blot analysis (Figure 1B). Nucleic acid substrates at different concentrations illustrate the high sensitivity of the biotin signal, with a detectable signal of 1 nM oligo after a relatively short exposure time for 1-3 s (Figure 2A). The wild-type MEIOB-A protein, but not the mutant MEIOB-E and MEIOB-C proteins, bind strongly to 36 nt biotin-labeled ssDNA substrates (the same length and sequence as used previously26) (Figure 2B) and cleave the substrates into ladders (Figure 2C).
The in vitro assay of MEIOB proteins with RNA oligos of the same sequence as ssDNA substrates used in Figure 2B,C illustrates binding capacity and exonuclease activity of MEIOB on 36 nt single-stranded RNA (ssRNA) (Figure 3A,B). Binding activity of MEIOB with DNA and RNA was further quantitatively analyzed (Figure 3C). Additionally, FLAG-tagged MOV10 proteins were purified from HEK293T cells (Figure 4A). To measure the helicase activity of MOV10, a duplex RNA was designed (same length but different sequence than used previously16) bearing an 18 nt 5' overhang (Figure 4B). When the biotin-labeled RNA duplex was incubated with MOV10 in the presence of ATP, a lower band corresponding to the released single-stranded biotin-labeled RNA appeared with increasing time, reflective of the MOV10’s function as an RNA helicase. Lastly, to reduce costs, it was attempted to optimize the usage of reagents for chemiluminescence detection of the biotin label. It was found that a two-fold dilution of the chemiluminescent nucleic acid detection kit did not negatively affect the chromogenic sensitivity of the biotin-streptavidin system, and excitingly, the self-made reagents worked almost equally well (Figure 5).
Figure 1: Purification of MEIOB proteins. (A) Schematic representation of the MEIOB constructs used in this study26. MEIOB contains an OB domain. All MEIOB constructs (A, C, E) were expressed as GST fusion proteins. (B) Coomassie blue staining and western blot analysis of the MEIOB proteins purified using GST-bacteria system. The red arrows indicate the positions of purified MEIOB proteins. Bands at approximately 26 KDa correspond to glutathione. For western blot, anti-GST antibody was used with 1:6000 dilution. Please click here to view a larger version of this figure.
Figure 2: In vitro assays of MEIOB-ssDNA interactions. (A) Signal strength test of different concentrations of 36 nt biotin-labeled ssDNA. (B) EMSA result of MEIOB protein binding to biotin 5' end-labeled DNA substrates (10% native gel). (C) MEIOB-mediated cleavage of biotin 5' end-labeled DNA substrates (20% native gel). Please click here to view a larger version of this figure.
Figure 3: In vitro assays of MEIOB-ssRNA interactions. (A) EMSA result of MEIOB protein binding to biotin 5' end-labeled RNA substrates (10% native gel). (B) MEIOB-mediated cleavage of biotin 5' end-labeled RNA substrates (20% native gel). (C) Plot of percentage of DNA/RNA-bound versus MEIOB-A concentration. Please click here to view a larger version of this figure.
Figure 4: Purified MOV10 protein and its unwinding of 5' tailed dsRNA in vitro. (A) Coomassie blue staining of MOV10 protein purified using the FLAG-HEK293T system. The red arrows indicate the positions of purified MOV10 protein. Bands on the Coomassie gel with a molecular weight of approximately 55 kDa correspond to the heavy immunoglobulin chain (IgG) from the FLAG antibody. (B) MOV10 unwinds 5' tailed dsRNA with increasing time (10, 30, 60 min) at 37 °C. ssRNA = 18 nt single-stranded RNA, dsRNA = 54 nt double-stranded RNA with an 18 nt 5' tail (20% native gel). Please click here to view a larger version of this figure.
Figure 5: Alternative methods of using biotin chromogenic reagents on MEIOB assay. Commercial standard volume: instructed by chemiluminescent nucleic acid detection kit; 2x diluted commercial volume: two-fold dilution of each buffer in chemiluminescent nucleic acid detection kit, self-made reagents: see details in step 3.7.3. Please click here to view a larger version of this figure.
Table 1: Primers used to PCR amplify the gene fragments of Meiob and Mov10. The bold letters in forward and reverse primers are BamHI and NotI cutting sites; the italic bold letters in a reverse primer are XhoI cutting sites; the bold letters in boxes indicate the nucleotides corresponding to the point mutation R235A.
Table 2: Sequences of DNA/RNA substrates used in this work.
Investigating protein-nucleic acid interactions is critical to our understanding of molecular mechanisms underlying diverse biological processes. For example, MEIOB is a testis-specific protein essential for meiosis and fertility in mammals25,26,27. MEIOB contains an OB domain that binds to single-stranded DNA and exhibits 3' to 5' exonuclease activity26, which directly relates to its physiological relevance during meiotic recombination. As another example, MOV10 is an RNA helicase with ubiquitous function that may associate with RNA secondary structures16. Accordingly, MOV10 displays broad RNA-binding properties and 5' to 3' RNA duplex unwinding activity16. The studies reporting the above-mentioned biochemical activities of these proteins relied on the use of 32P isotope to label nucleic acids for in vitro assays. In the present study, we have established protocols for a series of biotin-labeled in vitro experiments of MEIOB and MOV10 function. These protocols begin with the preparation of active proteins and ended with imaging of biotin signals.
Specifically, in line with previous studies25,26, MEIOB proteins were overexpressed in bacteria with and purification yielded one single band with strong Coomassie staining signal after gel electrophoresis. However, purification of full-length MOV10 protein was more effective when overexpressed as FLAG-tag-fused protein in HEK293T cells than as a GST-fused protein in bacteria (data not shown). To obtain sufficient amounts of protein at adequate purity for subsequent reactions, these two systems of protein purification need to be compared to determine the most suitable method for proteins with different sizes and/or properties. Nucleic acids were then labeled using biotin instead of 32P as substrate and obtained robust signal when examining the nucleic acid-binding affinity or nucleic acid-processing activities of both proteins. However, as proteins purified from bacteria are frequently contaminated with RNase, it is difficult to rule out the possibility that the cleavage activity seen during the in vitro reaction may in part result from contaminating RNase. In vitro assays with MEIOB mutants with reduced catalytic activity (truncated and point mutant) showed substantial impairment of RNA substrate processing, but possible RNase contamination cannot be excluded. The results obtained with each of MEIOB constructs acting on ssDNA and MOV10 unwinding dsRNA are similar to those obtained in previous study16,26. However, MEIOB processes DNA to generate a smear, while a more discrete band is seen with RNA according to the experimental results (Figure 2C and Figure 3B). Possibly, MEIOB has differential binding abilities to DNA and RNA substrate (Figure 2B, Figure 3A,C), which leads to the difference in their cleavage products. It may also be possible that MEIOB cleaves DNA and RNA in a distinct manner. The exact role of MEIOB in RNA processing remains to be further investigated (for example, using FLAG-tag-fused MEIOB protein expressed in HEK293T cells).
Biotin-labeled nucleic acid probes are advantageous over 32P-labeled probes in that they do not require specific protection and waste disposal. Secondly, biotin-labeled probes can be stably preserved for at least 1 year at -20 °C, whereas 32P-labeled probes last only for 2 weeks. Hence, the same batch of the biotin-labeled nucleic acids can be used over a long period of time, maintaining reproducibility of experiments. Finally, rapid autoradiography of radioactive probes may depend on expensive instruments such as phosphor screen. In contrast, all biotin-labeled assays described here can be performed within a day and do not require special equipment. The drawbacks of biotin labeling encompass mainly additional experimental steps including gel transfer and chemiluminescence that are necessary to detect biotin-labeled substrates but may additionally require optimization or troubleshooting. Another general weakness is the relatively low sensitivity of biotin-labeling compared with that of radioisotope-labeling. In these assays, nonetheless, well-visible detection of very low concentration of nucleic acids was achieved (Figure 2A).
In addition, semi-dry gel transfer apparatus is suitable for transferring longer-than-regular gels to membranes. Compared with wet transfer, semi-dry transfer is faster especially for nucleic acids, and yields a low background signal. Furthermore, costs of the chromogenic reaction of the biotin-streptavidin system were cut by either diluting the commercial reagents or making our own, both of which achieved similar signals. The detection sensitivity of the self-made reagents may not seem that high, albeit sufficient herein (Figure 5C), but it can be enhanced by extending the blocking time (unpublished data). Also, the signals can be enhanced with an increased concentration of the nucleic acid probe used for the assays. Given the above experimental evidence, the biotin label may be an advantageous substitute for 32P in multiple in vitro biochemical assays.
Collectively, this protocol offers a biotin-labeled platform for the study of protein-nucleic acid interactions that proves to be robust, reliable, efficient, and affordable.
The authors have nothing to disclose.
We thank P. Jeremy Wang (University of Pennsylvania) for helpful edits and discussions. We also thank Sigrid Eckardt for language editing. K. Z. was supported by National Key R&D Program of China (2016YFA0500902, 2018YFC1003500) and National Natural Science Foundation of China (31771653). L. Y. was supported by National Natural Science Foundation of China (81471502, 31871503) and Innovative and Entrepreneurial Program of Jiangsu Province. J. N. was supported by Zhejiang Medical Science and Technology Project (2019KY499). M. L. was supported by grants of National Natural Science Foundation of China (31771588) and the 1000 Youth Talent Plan.
Equipment | |||
Centrifuge | Eppendorf, Germany | 5242R | |
Chemiluminescent Imaging System | Tanon, China | 5200 | |
Digital sonifer | Branson, USA | BBV12081048A | 450 Watts; 50/60 HZ |
Semi-dry electrophoretic blotter | Hoefer, USA | TE77XP | |
Tube Revolver | Crystal, USA | 3406051 | |
UV-light cross-linker | UVP, USA | CL-1000 | |
Materials | |||
Amicon Ultra-4 Centrifugal Filter | Milipore, USA | UFC801096 | 4 ml/10 K |
Nylon membrane | Thermo Scientific, USA | TG263940A | |
TC-treated Culture Dish | Corning, USA | 430167 | 100 mm |
TC-treated Culture Dish | Corning, USA | 430597 | 150 mm |
Microtubes tubes | AXYGEN, USA | MCT-150-C | 1.5 mL |
Tubes | Corning, USA | 430791 | 15 mL |
Reagents | |||
Ampicillin | SunShine Bio, China | 8h288h28 | |
Anti-FLAG M2 magnetic beads | Sigma, USA | M8823 | |
ATP | Thermo Scientific, USA | 591136 | |
BCIP/NBT Alkaline Phosphatase Color Development Kit | Beyotime, China | C3206 | |
CelLyticTM M Cell Lysis Reagent | Sigma, USA | 107M4071V | |
ClonExpress II one step cloning kit | Vazyme, China | C112 | |
Chemiluminescent Nucleic Acid Detection Kit | Thermo Scientific, USA | T1269950 | |
dNTP | Sigma-Aldrich, USA | DNTP100-1KT | |
DMEM | Gibco, USA | 10569044 | |
DPBS buffer | Gibco, USA | 14190-136 | |
EDTA | Invitrogen, USA | AM9260G | 0.5 M |
EDTA free protease inhibitor cocktail | Roche, USA | 04693132001 | |
EndoFree Maxi Plasmid Kit | Vazyme, China | DC202 |
|
FastPure Gel DNA Extraction Mini Kit | Vazyme, China | DC301-01 | |
FBS | Gibco, USA | 10437028 | |
FLAG peptide | Sigma, USA | F4799 | |
Glycerol | Sigma, USA | SHBK3676 | |
GST Bulk Kit | GE Healthcare, USA | 27-4570-01 | |
HEPES buffer | Sigma, USA | SLBZ2837 | 1 M |
IPTG | Thermo Scientific, USA | 34060 | |
KoAc | Sangon Biotech, China | 127-08-02 | |
Lipofectamin 3000 Transfection Reagent | Thermo Scientific, USA | L3000001 | |
MgCl2 | Invitrogen, USA | AM9530G | 1 M |
NaCl | Invitrogen, USA | AM9759 |
5 M |
NP-40 | Amresco, USA | M158-500ML | |
Opti-MEM medium | Gibco, USA | 31985062 | |
PBS | Gibco, USA | 10010023 | PH 7.4 |
RNase Inhibitor | Promega, USA | N251B | |
Streptavidin alkaline phosphatase | Promega, USA | V5591 | |
TBE | Invitrogen, USA | 15581044 | |
Tris-HCI Buffer | Invitrogen, USA | 15567027 | 1 M, PH 7.4 |
Tris-HCI Buffer | Invitrogen, USA | 15568025 | 1 M, PH 8.0 |
Tween-20 | Sangon Biotech, China | A600560 |